Return on Investment: Medical Savings of an Employer‐Sponsored Digital Intensive Lifestyle Intervention for Weight Loss

OBJECTIVE: This study aimed to determine the medical cost impact and return on investment (ROI) of a large, commercial, digital, weight‐management intensive lifestyle intervention (ILI) program (Real Appeal). METHODS: Participants in this program were compared with a control group matched by age, sex, geographic region, health risk, baseline medical costs, and chronic conditions. Medical costs were defined as the total amount paid for all medical expenses, inclusive of both the insurers’ and the study participants’ responsibility. RESULTS: In the 3 years following program registration, the intent‐to‐treat (ITT) cohort had significantly lower medical expenditures than the matched controls, with an average of −$771 or 12% lower costs (P = 0.002). Among 4,790 ITT participants, a total savings of $3,693,090 compared with total program costs of $1,639,961 translated into a 2.3:1 ROI. Program completers (n = 3,990), who attended more sessions than the overall ITT group, had greater mean weight loss (−4.4%), greater cost savings (−$956 or 14%), and an ROI of 2.0:1 over the 3‐year time frame compared with matched controls. CONCLUSIONS: The findings demonstrated that the digital weight‐management ILI was associated with a significantly positive ROI. Employers and payers willing to cover the cost of an ILI that produces both weight loss and demonstrated cost benefits can improve health and save money for their population with overweight or obesity.